South Korea's top court clears SK Bioscience’s vaccine of patent violation, unlocking export potential and global market ...

South Sudan has introduced the pneumococcal conjugate vaccine (PCV) and rotavirus vaccine into its national immunization ...

The introduction of the heptavalent pneumococcal conjugate vaccine (PCV7) in the U.S. in 2000 was a welcome addition to our preventive armamentarium; however, questions remain regarding the degree ...

Pneumococcal meningitis was associated with a case-fatality rate of almost 30% in children with sickle cell disease, a study ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...

VOV.VN - French President Emmanuel Macron and Vietnamese Vice President Vo Thi Anh Xuan launched the groundbreaking ceremony ...

South Sudan, in partnership with United Nations agencies, on Tuesday launched two vaccines to prevent pneumonia and severe ...

South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.

Vaccine and biotech company SK bioscience announced Wednesday that it the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large ...

WHO, in collaboration with Somali federal and regional governments, to vaccinate 3.1M children under age of 5 during ...